Want to see CHE full AI Analyst Report?
CHE Stock Chart & Stats
$511.13
$8.12(1.61%)
At close: 4:00 PM EDT
$511.13
$8.12(1.61%)
Day’s Range― - ―
52-Week Range$365.21 - $553.00
Previous CloseN/A
Volume113.91K
Average Volume (3M)186.16K
Market Cap
$7.07B
Enterprise Value$6.44K
Total Cash (Recent Filing)$40.22M
Total Debt (Recent Filing)$294.79M
Price to Earnings (P/E)26.7
Beta0.26
Next Earnings
Nov 03, 2026EPS Estimate
6.48Next Dividend Ex-DateN/A
Dividend Yield0.45%
Share Statistics
EPS (TTM)19.92
Shares Outstanding13,274,104
10 Day Avg. Volume157,729
30 Day Avg. Volume186,159
Financial Highlights & Ratios
PEG Ratio-2.78
Price to Book (P/B)6.29
Price to Sales (P/S)2.43
P/FCF Ratio18.93
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$569.00Price Target Upside11.32% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)24.34
Revenue Forecast (FY)$2.69B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistent excess operating cash (OCF ~1.22x net income) and sizable FCF provide durable funding for capex, tuck‑ins, franchise buybacks and working capital. Strong cash conversion enhances resilience to reimbursement shocks and underpins shareholder returns and reinvestment capacity.
Solid Operating ProfitabilitySustained double‑digit EBITDA and healthy net margins across VITAS and Roto‑Rooter reflect operational scale and pricing power. Robust margins support return on equity and provide buffer against cost pressures, enabling long‑term margin sustainability and investment in growth initiatives.
Upgraded Guidance & Medicare Cap ImprovementRaised midyear guidance and a smaller expected Medicare cap billing limitation materially improve revenue visibility and reduce regulatory overhang. Better cap positioning plus stronger ADC/revenue outlook supports durable margin expansion and lowers downside to reimbursement sensitivity.
Bears Say
Margin Compression And FCF SlowdownEroding margins alongside a meaningful drop in FCF growth and a rising debt‑to‑equity ratio reduce financial flexibility. Over time this can constrain capital allocation choices, increase borrowing costs in stress scenarios, and limit ability to fund organic or acquisition growth without margin recovery.
Regulatory/program‑integrity RiskHeightened industry scrutiny and a CON moratorium directly affect VITAS expansion timing and increase compliance costs. Structural regulatory shifts or tighter CMS program‑integrity rules could curb organic growth, raise operating costs and complicate revenue recognition over the medium term.
Roto‑Rooter Lead And Operational HeadwindsSustained deterioration in free leads and higher paid acquisition costs weaken unit economics for Roto‑Rooter. Coupled with water‑restoration transition disruptions that reduced job revenue, these structural marketing and operating issues can pressure long‑term margins and require persistent investment to remedy.
Chemed News
CHE FAQ
What was Chemed Corporation’s price range in the past 12 months?
Chemed Corporation lowest stock price was $365.20 and its highest was $553.00 in the past 12 months.
What is Chemed Corporation’s market cap?
Chemed Corporation’s market cap is $7.07B.
When is Chemed Corporation’s upcoming earnings report date?
Chemed Corporation’s upcoming earnings report date is Nov 03, 2026 which is in 87 days.
How were Chemed Corporation’s earnings last quarter?
Chemed Corporation released its earnings results on Jul 28, 2026. The company reported $6.06 earnings per share for the quarter, beating the consensus estimate of $5.6 by $0.46.
Is Chemed Corporation overvalued?
According to Wall Street analysts Chemed Corporation’s price is currently Undervalued.
Does Chemed Corporation pay dividends?
Chemed Corporation pays a Quarterly dividend of $0.7 which represents an annual dividend yield of 0.45%. See more information on Chemed Corporation dividends here
What is Chemed Corporation’s EPS estimate?
Chemed Corporation’s EPS estimate is 6.48.
How many shares outstanding does Chemed Corporation have?
Chemed Corporation has 13,274,104 shares outstanding.
What happened to Chemed Corporation’s price movement after its last earnings report?
Chemed Corporation reported an EPS of $6.06 in its last earnings report, beating expectations of $5.6. Following the earnings report the stock price went up 4.198%.
Which hedge fund is a major shareholder of Chemed Corporation?
Currently, no hedge funds are holding shares in CHE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chemed Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$569.00 (11.32% Upside)
$569.00 (11.32% Upside)
Blogger Sentiment
Bullish
CHE Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 14.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 2.9%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.98%
12-Months-Change
Fundamentals
Return on Equity
0.45%
Trailing 12-Months
Asset Growth
-8.05%
Trailing 12-Months
Company Description
Chemed Corporation
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
CHE Company Deck
CHE Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was decidedly positive: VITAS delivered strong top-line and profitability beats, materially improved Medicare cap positioning, and management raised full-year guidance across ADC, revenue and EBITDA margin while consolidated cash generation exceeded expectations. Roto-Rooter showed commercial momentum, margin recovery in gross profit, and strategic franchise buybacks, but faces persistent lead-generation/marketing cost pressure, water restoration transitional issues and modest margin drag. Regulatory oversight and mix/length-of-stay dynamics at VITAS are noted risks but were framed as managed and not materially impairing guidance.View all CHE earnings summariesCHE Stock 12 Month Forecast
Average Price Target
$569.00
▲(11.32% Upside)
Technical Analysis
Ownership Overview
1.10% Insiders
30.78% Mutual Funds
10.61% Other Institutional Investors
28.51% Public Companies and
Individual Investors